Journal
PEDIATRIC RESEARCH
Volume 49, Issue 5, Pages 614-617Publisher
NATURE PUBLISHING GROUP
DOI: 10.1203/00006450-200105000-00002
Keywords
-
Categories
Funding
- NHLBI NIH HHS [R01-HL55338] Funding Source: Medline
- NIDDK NIH HHS [R01-DK39869] Funding Source: Medline
Ask authors/readers for more resources
Hypoxia-inducible factor 1 (HIF-1) is a transcriptional activator that mediates changes in gene expression in response to changes in cellular oxygen concentrations. HIF-1 is a heterodimer consisting of an oxygen-regulated HIF-1 alpha subunit and a constitutively expressed HIF-1 beta subunit. In mice, complete HIF-1 alpha deficiency results in embryonic lethality at midgestation because of cardiac and vascular malformations. Analyses of animal and cell culture models as well as human tissue have provided evidence that HIF-1 plays important roles in the pathophysiology of preeclampsia, intrauterine growth retardation, hypoxia-mediated pulmonary hypertension, and cancer. HIF-1 pro motes neovascularization in response to myocardial or retinal ischemia by activating transcription of the gene encoding vascular endothelial growth factor. HIF-1 may also mediate the protective response to cerebral ischemia known as late-phase preconditioning.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available